Search
for
Sort by
Research 421–450 of 1000+
- Characteristics of flutamide action on prostatic and testicular functions in the rat
- The Double Edge Sword of Testosterone’s Role in the COVID-19 Pandemic
- Effects of lifelong testosterone exposure on health and disease using Mendelian randomization
- CAG Repeat Testing of Androgen Receptor Polymorphism: Is This Necessary for the Best Clinical Management of Hypogonadism?
- Nonsteroidal Selective Androgen Receptors Modulators (SARMs): Designer Androgens with Flexible Structures Provide Clinical Promise
- Does a male polycystic ovarian syndrome equivalent exist?
- Androgenetic alopecia as an early marker of benign prostatic hyperplasia
- Androgen antagonists in androgen target tissues
- Expression and function of nuclear receptor co-activator 4: evidence of a potential role independent of co-activator activity
- Roles of Type 10 17beta-Hydroxysteroid Dehydrogenase in Intracrinology and Metabolism of Isoleucine and Fatty Acids
- Non-canonical dimerization of the androgen receptor and other nuclear receptors: implications for human disease
- Testosterone therapy in men: Clinical and pharmacological perspectives
- Dutasteride for the treatment of benign prostatic hyperplasia
- Ganoderma lucidum is an inhibitor of testosterone-induced prostatic hyperplasia in rats
- Benign Prostatic Hyperplasia: A Disorder of Androgen Metabolism in the Male
- Finasteride: The First 5α-Reductase Inhibitor
- Simultaneous quantitation of nine hydroxy-androgens and their conjugates in human serum by stable isotope dilution liquid chromatography electrospray ionization tandem mass spectrometry
- Synthesis and Evaluation of 2‘-Substituted 4-(4‘-Carboxy- or 4‘-carboxymethylbenzylidene)-<i>N</i>-acylpiperidines: Highly Potent and in Vivo Active Steroid 5α-Reductase Type 2 Inhibitors
- Meta-Analysis of Randomized Clinical Trials of Finasteride
- Corn silk extract improves benign prostatic hyperplasia in experimental rat model
- Anti-Androgen Effects of Extracts and Compounds from<i>Ganoderma lucidum</i>
- Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels
- Recent Advances in the Chemistry and Pharmacological Activity of New Steroidal Antiandrogens and 5α-Reductase Inhibitors
- Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis
- Benign prostatic hyperplasia and male lower urinary symptoms: A guide for family physicians
- Synthesis and structure–activity studies of side-chain derivatized arylhydantoins for investigation as androgen receptor radioligands
- Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study
- The Influence of Age-Related Cues on Health and Longevity
- Safety aspects of androgen treatment with 5α-dihydrotestosterone
- Therapeutic Androgen Receptor Ligands